Current Edition


Seagen CEO Siegall resigns amid domestic violence investigation

One week after placing CEO Clay Siegall on leave, cancer drug developer Seagen announced Monday that its cofounder and longtime leader has resigned as he …

Continue Reading →

Seagen to expand, add jobs with new cancer drug factory

Dive Brief: Seagen, the largest biotechnology company in the Seattle area, has unveiled plans for a manufacturing facility to help provide “greater control and flexibility” …

Continue Reading →

Lilly deepens research ties in China with biotech deal

Lilly’s deal with Regor is another example of large pharmaceutical companies in the U.S. and Europe showing interest in Chinese biotechs for their research, rather …

Continue Reading →